A sensitive and reproducible HPLC method has been developed for quantitative analysis of telmisartan. The drug was separated from its degradation products on a C18 column at ambient temperature with methanol-water 80:20 (v/v), pH 4.0 (adjusted by addition of orthophosphoric acid), as mobile phase at a flow rate of 1.0 mL min−1. Under these conditions the retention time of telmisartan was 4.85 ± 0.05 min. Quantification on the basis of peak area was achieved by UV detection at 225 nm; calibration plots were linear in the concentration range 10–60 μg mL−1. When the method was applied to a pharmaceutical formulation there was no chromatographic interference from tablet excipients. The method was validated for precision, robustness, recovery, and limits of detection and quantification. The drug was subjected to acidic and alkaline hydrolysis, and oxidising, dry heat, wet heat, and photodegrading conditions. Because the method could effectively separate the drug from its degradation products, it can be regarded as stability indicating.
[1]. J.M. Neutel D.H. Smith 1998 Adv. Ther. 15 206.
[2]. S. Hillaert W. Van den Bossche 2003 J. Pharm. Biomed. Anal. 31 329.
[3]. S. Hillaert T.R.M. De Beer J.O. De Beer W. Van den Bossche 2003 J. Chromatogr. A 984 135.
[4]. M. Xu J. Song Y. Liang 2004 J. Pharm. Biomed. Anal. 34 681.
[5]. M.S. Palled P.M.N. Rajesh M. Chatter 2005 AR Bhat, IJPS 67 108.
[6]. N. Torrealday L. Gonzalez R.M. Alonso R.M. Jimenz E. Ortiz Lastra 2003 J. Pharm. Biomed. Anal. 32 847.
[7]. B. Chen Y. Liang Y. Wang F. Deng P. Zhou F. Guo L. Haung 2005 Anal. Chim. Acta 540 367.
[8]. P. Li Y. Wang Y. Wang Y. Tang J. P. Fawcett Y. Cui J. Gu 2005 J. Chromatogr. B 828 126.
[9]. C. Hempen L. Gläsle-Schwarz U. Kunz U. Karst 2006 Anal. Chim. Acta 560 35.
[10]. C. Hempen L. Gläsle-Schwarz U. Kunz U. Karst 2006 Anal. Chim. Acta 560 41.
[11]. ICH, Q1A Stability Testing of New Drug Substances and Products, in: Proceedings of the International Conference on Harmonization, Geneva, October, 1993.
[12]. ICH, Q2A, Harmonised Tripartite Guideline, Text on Validation of Analytical Procedures, IFPMA, in: Proceedings of the International Conference on Harmonization, Geneva, March, 1994.
[13]. ICH, Q2B, Harmonised Tripartite Guideline, Validation of Analytical Procedure: Methodology, IFPMA, in: Proceedings of the International Conference on Harmonization, Geneva, March, 1996.
[14]. ICH Guidance on Analytical Method Validation, in: Proceedings of the International Convention on Quality for the Pharmaceutical Industry, Toronto, Canada, September, 2002.